In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Back in Fashion: Discovery Platforms (Certain Kinds, at Least)

Executive Summary

After the millennial boom in genome-related financings, platform companies went into hiding, surfacing again a few years later in product costume. But much of that has changed. Platforms are getting fed again-largely because, one step higher on the food chain, buyers have an appetite for them.

Related Content

Private Biotech M&A Review: Has the Market Lost Steam?
Big Pharma's Leap into Biologics: Bridging both Scientific and Cultural Gaps
Alnylam Takes Platform Monetization to a Whole New and Non-Exclusive Level


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts